Respiratory Profile, Region 2, Mid-Atlantic (DC, DE, MD, NC, VA), Serum

Casandra

Casandra Test Code MC95153Version 1 (DRAFT)

Performing Lab

Lab Mayo Clinic LabLab Test ID RPR2CPT Codes 82785, 86003

Respiratory Profile, Region 2, Mid-Atlantic (DC, DE, MD, NC, VA), Serum

Clinical Use

Use

This test is useful for assessing sensitization to various inhalant allergens commonly found in the Mid-Atlantic region, including the District of Columbia, Delaware, Maryland, North Carolina, and Virginia. It helps define the allergen responsible for eliciting signs and symptoms and identify allergens responsible for allergic responses or anaphylactic episodes. The test also aids in confirming sensitization prior to beginning immunotherapy and investigating the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.

Special Instructions

For a listing of allergens available for testing, refer to the Allergens - Immunoglobulin E (IgE) Antibodies PDF. If not ordering electronically, complete, print, and send an Allergen Test Request (T236) with the specimen.

Limitations

The test is not useful for patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in whom the medical management does not depend upon identification of allergen specificity. Elevated total IgE is not diagnostic for allergic disease and must be interpreted in the clinical context. False-positive results for IgE antibodies can occur in patients with markedly elevated serum IgE (>2500 kU/L) due to nonspecific binding.

Test Details

FDA Approved

New York Approved

Methodology

Immunoassay (Other)

Biomarkers

24 targets

Alternaria Tenuis, IgEAspergillus Fumigatus, IgEBermuda Grass, IgEBox Eld/Maple, S, IgECat Epithelium, IgECladosporium, IgECockroach, IgECottonwood, IgE+16 more